Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs

(MedPage Today) -- SGLT2 inhibitors were associated with a lower or similar fracture risk compared with incretin-based antidiabetic agents in postmenopausal women with type 2 diabetes, according to a claims-based study involving two independent...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news